Glutamate-mediated calcium signaling: A potential target for lithium action

Neuroscience

Volumn 161, Issue 4, 2009, Pages 1126-1134

  Sourial Bassillious, N ^a   Rydelius, P A ^a   Aperia, A ^a   Aizman, O ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

hippocampus; mGluR; mood stabilizers; NMDA; rat

Indexed keywords

CALCIUM; CALCIUM ION; GLUTAMIC ACID; LITHIUM; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 5; MUSCARINIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; BIPOLAR DISORDER; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; DRUG CONCENTRATION; DRUG EXPOSURE; EMBRYO; HIPPOCAMPUS; INTERPERSONAL COMMUNICATION; MENTAL DISEASE; MENTAL HEALTH; MOOD DISORDER; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SUICIDE;

ANIMALS; ANTIMANIC AGENTS; CALCIUM; CALCIUM SIGNALING; CARBACHOL; CELL MEMBRANE; CELLS, CULTURED; DOWN-REGULATION; ENDOPLASMIC RETICULUM; GLUTAMIC ACID; HIPPOCAMPUS; LITHIUM CHLORIDE; MUSCARINIC AGONISTS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, MUSCARINIC; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 66049113360     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.04.013     Document Type: Article

References (47)

1. Bauer M., Alda M., Priller J., Young L.T., and International Group for the Study of Lithium Treated Patients (IGSLI). Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders. Pharmacopsychiatry 36 Suppl 3 (2003) S250-S254
2. Beaulieu J.M., Marion S., Rodriguiz R.M., Medvedev I.O., Sotnikova T.D., Ghisi V., Wetsel W.C., Lefkowitz R.J., Gainetdinov R.R., and Caron M.G. A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell 132 1 (2008) 125-136
3. Berridge M.J., Downes C.P., and Hanley M.R. Neural and developmental actions of lithium: a unifying hypothesis. Cell 59 (1989) 411-419
4. Bertolino M., and Vicini S. Voltage-dependent block by strychnine of N-methyl-D-aspartic acid-activated cationic channels in rat cortical neurons in culture. Mol Pharmacol 34 2 (1988) 98-103
5. Bhave G., Nadin B.M., Brasier D.J., Glauner K.S., Shah R.D., Heinemann S.F., Karim F., and Gereau IV R.W. Membrane topology of a metabotropic glutamate receptor. J Biol Chem 278 32 (2003) 30294-30301
6. Brunet G., Cerlich B., Robert P., Dumas S., Souetre E., and Darcourt G. Open trial of a calcium antagonist, nimodipine, in acute mania. Clin Neuropharmacol 3 (1990) 224-228
7. Carli M., Anand-Srivastava M.B., Molina-Holgado E., Dewar K.M., and Reader T.A. Effects of chronic lithium treatments on central dopaminergic receptor systems: G proteins as possible targets. Neurochem Int 24 1 (1994) 13-22
8. Fährmann M., Heinzmann A., and Seidler U. CaMKII is activated and translocated to the secretory apical membrane during cholinergically conveyed gastric acid secretion. Cell Signal 14 2 (2002) 161-168
9. 2+ influx: how many mechanisms for how many channels?. Trends Pharmacol Sci 15 3 (1994) 77-83
10. 2+-transport ATPase in rat skeletal muscle sarcoplasmic reticulum vesicles. Biochem Pharmacol 37 5 (1988) 978-981
11. Goodwin F.K., and Jamison K.R. Manic-depressive illness (1990), Oxford University Press, New York
12. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260 6 (1985) 3440-3450
13. Hahn C.G., Umapathy, Wang H.Y., Koneru R., Levinson D.F., and Friedman E. Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients. J Psychiatr Res 39 4 (2005) 355-363
14. Hernández-Fonseca K., and Massieu L. Disruption of endoplasmic reticulum calcium stores is involved in neuronal death induced by glycolysis inhibition in cultured hippocampal neurons. J Neurosci Res 15 2 (2005) 196-205
15. Hough C.J., Irwin R.P., Gao X.M., Rogawski M.A., and Chuang D.M. Carbamazepine inhibition of N-methyl-D-aspartate-evoked calcium influx in rat cerebellar granule cells. J Pharmacol Exp Ther 276 1 (1996) 143-149
16. Kelly K.M., Gross R.A., and Macdonald R.L. Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neurons. Neurosci Lett 116 1-2 (1990) 233-238
17. Kew J.N., and Kemp J.A. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology (Berl) 179 1 (2005) 4-29
18. Kirschstein T., Bauer M., Müller L., Rüschenschmidt C., Reitze M., Becker A.J., Schoch S., and Beck H. Loss of metabotropic glutamate receptor-dependent long-term depression via downregulation of mGluR5 after status epilepticus. J Neurosci 27 29 (2007) 7696-7704
19. Koss D.J., Hindley K.P., Riedel G., and Platt B. Modulation of hippocampal calcium signaling and plasticity by serine/threonine protein phosphatases. J Neurochem 102 4 (2007) 1009-1023
20. Kumar A., and Foster T.C. Enhanced long-term potentiation during aging is masked by processes involving intracellular calcium stores. J Neurophysiol 91 6 (2004) 2437-2444
21. Maj M. The impact of lithium prophylaxis on the course of bipolar disorder: a review of the research evidence. Bipolar Disord 2 (2000) 93-101
22. Manji H.K., Moore G.J., Rajkowska G., and Chen G. Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry 6 (2000) 578-593
23. Mao L., and Wang J.Q. Primary striatal neuronal culture. Methods Mol Med 79 (2003) 379-386
24. 2+ the underlying theme in the proposed mechanisms for the pharmacological action of lithium salts in bipolar disorder?. Acc Chem Res 39 4 (2006) 283-291
25. Musante V., Neri E., Feligioni M., Puliti A., Pedrazzi M., Conti V., Usai C., Diaspro A., Ravazzolo R., Henley J.M., Battaglia G., and Pittaluga A. Presynaptic mGlu1 and mGlu5 autoreceptors facilitate glutamate exocytosis from mouse cortical nerve endings. Neuropharmacology 55 4 (2008) 474-482
26. Muzina D.J., and Calabrese J.R. Maintenance therapies in bipolar disorder: focus on randomized controlled trials. Aust N Z J Psychiatry 39 8 (2005) 652-661
27. Nakanishi S. Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity. Neuron 13 (1994) 1031-1037
28. Nocjar C., Hammonds M.D., and Shim S.S. Chronic lithium treatment magnifies learning in rats. Neuroscience 150 4 (2007) 774-788
29. Nonaka S., Hough C.J., and Chuang D.M. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci U S A 95 5 (1998) 2642-2647
30. Notenboom R.G., Hampson D.R., Jansen G.H., van Rijen P.C., van Veelen C.W., van Nieuwenhuizen O., and de Graan P.N. upregulation of hippocampal metabotropic glutamate receptor 5 in temporal lobe epilepsy patients. Brain 129 Pt 1 (2006) 96-107
31. Perova T., Wasserman M.J., Li P.P., and Warsh J.J. Hyperactive intracellular calcium dynamics in B lymphoblasts from patients with bipolar I disorder. Int J Neuropsychopharmacol 11 2 (2007) 185-196
32. Pietraszek M., Nagel J., Gravius A., Schäfer D., and Danysz W. The role of group I metabotropic glutamate receptors in schizophrenia. Amino Acids 32 2 (2007) 173-178
33. Pilc A., Chaki S., Nowak G., and Witkin J.M. Mood disorders: regulation by metabotropic glutamate receptors. Biochem Pharmacol 75 5 (2007) 997-1006
34. Pisani A., Gubellini P., Bonsi P., Conquet F., Picconi B., Centonze D., Bernardi G., and Calabresi P. Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons. Neuroscience 106 3 (2001) 579-587
35. Putney J.W. "Kissin' cousins": intimate plasma membrane-ER interactions underlie capacitative calcium entry. Cell 99 1 (1999) 5-8
36. 2+ release and inward currents in hippocampal CA1 pyramidal neurons. Neuropharmacology 46 8 (2004) 1057-1069
37. Rodriguez A.L., and Williams R. Recent progress in the development of allosteric modulators of mGluR5. Curr Opin Drug Discov Devel 10 6 (2007) 715-722
38. Schoepp D.D., Goldsworth J., Johnson B.G., Salhoff C.R., and Baker S.R. 3,5 Dihydroxyphenylglycine is a highly selective agonist for phosphoinositide-linked metabotropic glutamate receptors in the rat hippocampus. J Neurochem 63 (1994) 769-772
39. Severus W.E., Kleindienst N., Seemüller F., Frangou S., Möller H.J., and Greil W. What is the optimal serum lithium level in the long-term treatment of bipolar disorder-a review. Bipolar Disord 10 2 (2008) 231-237
40. Tu J.C., Xiao B., Naisbitt S., Yuan J.P., Petralia R.S., Brakeman P., Doan A., Aakalu V.K., Lanahan A.A., Sheng M., and Worley P.F. Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron 23 3 (1999) 583-592
41. Walden J., Grunze H., Bingmann D., Liu Z., and Dusing R. Calcium antagonistic effects of carbamazepine as a mechanism of action in neuropsychiatric disorders: studies in calcium dependent model epilepsies. Eur Neuropsychopharmacol 4 (1992) 455-462
42. Wang H.Y., and Friedman E. Effects of lithium on receptor-mediated activation of G proteins in rat brain cortical membranes. Neuropharmacology 38 3 (1999) 403-414
43. Wasserman M.J., Corson T.W., Sibony D., Cooke R.G., Parikh S.V., Pennefather P.S., Li P.P., and Warsh J.J. Chronic lithium treatment attenuates intracellular calcium mobilization. Neuropsychopharmacology 29 4 (2004) 759-769
44. Witkin J.M., Marek G.J., Johnson B.G., and Schoepp D.D. Metabotropic glutamate receptors in the control of mood disorders. CNS Neurol Disord Drug Targets 6 2 (2007) 87-100
45. Xiao B., Tu J.C., Petralia R.S., Yuan J.P., Doan A., Breder C.D., Ruggiero A., Lanahan A.A., Wenthold R.J., and Worley P.F. Homer regulates the association of group 1 metabotropic glutamate receptors with multivalent complexes of homer-related, synaptic proteins. Neuron 21 4 (1998) 707-716
46. Young A.H., and Hammond J.M. Lithium in mood disorders: increasing evidence base, declining use?. Br J Psychiatry 191 (2007) 474-476
47. Zhong J., and Lee W.H. Lithium: a novel treatment for Alzheimer's disease?. Expert Opin Drug Saf 6 4 (2007) 375-383